Black people and those with high levels of melanin in their skin have long been left out of efforts to combat skin cancer. Historically neglected both by sunscreen manufacturers and a medical community lagging in diversity and cultural competency, many people with dark skin tones have not been informed about sun safety or how to monitor their skin for damage or cancer.
Republicans say Democrats are wrong to claim that birth control could be the Supreme Court’s next target. But Democrats have plenty of evidence that it might be.
Tennessee expects to soon disenroll about 300,000 people from its Medicaid program. But families like the Lesters have suffered when bureaucracy and clerical mistakes caused them to unfairly lose coverage under the same program.
Music festival promoters are allowing distribution of overdose reversal medication as fentanyl deaths continue to surge. But nonprofits and volunteers are often left to do the work, and more controversial forms of harm reduction aren’t openly allowed.
A Houston woman was 18 weeks pregnant when her water broke. That means her fetus had virtually no chance of survival, and she was at risk of an infection that could threaten her future fertility and even her life. Following Texas’ law, the hospital made her wait until she was showing signs of serious infection to terminate the pregnancy.
More than two years into the pandemic, parents face a child care crisis. That’s why some hospitals are considering starting child care centers to address recruitment and retention troubles.
A lack of Native physicians means many tribal communities rely on doctors who don’t share their lived experience, culture, or spiritual beliefs. In Episode 9, meet two medical students working to join the ranks of Indigenous physicians.
The advocacy group American Commitment said empowering Medicare to negotiate drug prices would raid it of billions of dollars. Drug pricing experts say that that’s not the case and that such policies would instead reduce costs for the Medicare program and seniors.
Homes for pregnant girls may seem like a vestige of the past. But they still exist and, in light of the Supreme Court’s recent ruling on abortion, may become more necessary.
Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.
Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.
Some people living with HIV and some state health officials are raising concerns about part of the federal effort to end the HIV epidemic: a new technology that analyzes blood samples to find emerging outbreaks. The critics say it’s too invasive and stigmatizing and might not be more effective than older public health approaches.
Sexual health clinics are scrambling to properly track, test, and treat hundreds of monkeypox patients. So far, it isn’t going well.
Spurred on by opposition to pandemic-related health mandates, a coalition of religious liberty groups, conservative think tanks, and Republican state attorneys general has filed a cascade of litigation seeking to rein in the powers of public health authorities.
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven’t received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.
A new federal rescue program that pays rural hospitals to shutter underused inpatient units and focus solely on emergency rooms and outpatient care hasn’t generated much interest yet.
The FDA has approved a cannabis-derived drug, Epidiolex, to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter CBD products in hopes of taming their seizures. But doctors and patients worry about the unregulated world of CBD, in which product ingredients can be a mystery.
Hospital-acquired pneumonia not tied to ventilators is one of the most common infections that strike within health care facilities. But few hospitals take steps to prevent it, which can be as simple as dutifully brushing patients’ teeth.
A network of organizations help women use medication to end early pregnancies safely. But it’s a legal gray area in Tennessee and other states that restrict abortion.